Rocket Lab (RKLB) stock surges 6.5% after KeyBanc's upgrade to Overweight with $135 price target. Nasdaq-100 inclusion set for June 22, 2026. The post Rocket LabRocket Lab (RKLB) stock surges 6.5% after KeyBanc's upgrade to Overweight with $135 price target. Nasdaq-100 inclusion set for June 22, 2026. The post Rocket Lab

Rocket Lab (RKLB) Stock Soars 6.5% on KeyBanc Upgrade and Nasdaq-100 Entry Confirmed

2026/06/15 21:56
Okuma süresi: 3 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen crypto.news@mexc.com üzerinden bizimle iletişime geçin.

Key Highlights

  • RKLB received an Overweight rating from KeyBanc with a $135 price target, suggesting approximately 40% potential upside
  • The company’s inclusion in the Nasdaq-100 Index is scheduled for June 22, 2026
  • Neutron rocket development continues on track for debut launch this year following resolution of January testing issue
  • First quarter revenue reached $200.35 million, representing a 63.4% year-over-year increase and surpassing $189.65 million analyst projections
  • Institutional investors hold 71.78% of shares, with several major funds expanding positions during Q1

Rocket Lab (RKLB) shares are changing hands at $102.39, marking a 6.50% gain on Monday, driven by a bullish analyst reassessment and the company’s confirmed addition to a major stock index.


RKLB Stock Card
Rocket Lab USA, Inc., RKLB

KeyBanc elevated its rating on RKLB to Overweight from Sector Weight while establishing a $135 price target. This valuation implies approximately 40% appreciation potential from current trading levels. The analyst firm maintained its existing financial projections.

The timing of the upgrade aligns with Rocket Lab‘s scheduled entry into the Nasdaq-100 on June 22. Such index additions typically generate buying pressure from over 200 exchange-traded and index funds tracking the benchmark, which manage more than $800 billion in combined assets.

KeyBanc highlighted Rocket Lab’s standing as the number two competitor in the commercial orbital launch industry. The company’s Electron vehicle has achieved approximately 90 successful orbital missions to date.

For many analysts, the Neutron rocket program represents the more significant catalyst. KeyBanc indicated it has developed improved clarity on the program’s status during recent months and verified that a January testing setback has been completely addressed. The Neutron vehicle remains scheduled for its inaugural flight within this calendar year.

Stifel recently boosted its RKLB price objective to $132 from $110 while reaffirming its Buy recommendation, pointing to robust revenue growth and an expanding contract pipeline.

First Quarter Performance Exceeds Projections

On May 7, Rocket Lab disclosed Q1 revenue totaling $200.35 million, surpassing the $189.65 million Wall Street consensus. This figure represented a 63.4% increase compared to the prior-year quarter.

Earnings per share registered at -$0.07, aligning with analyst expectations. The company recorded a net margin of negative 26.87% alongside a negative return on equity of 11.72%. Full-year EPS is projected at -$0.29 by the analyst community.

Shares have rocketed more than 300% over the trailing twelve months. The stock reached a 52-week peak of $151.00 and touched a low of $25.24, currently trading roughly 24% beneath its recent high. The 50-day moving average stands at $101.62.

Institutional Investors Continue Building Positions

Institutional stakeholders control 71.78% of outstanding RKLB shares. During Q1, AQR Capital Management expanded its holdings by more than 100%, purchasing an additional 92,849 shares. NewEdge Advisors boosted its position by over 1,800%. UBS Asset Management acquired 90,758 shares, elevating its total ownership to 773,548.

Entropy Technologies LP grew its stake by 18.5% in Q4, bringing its holdings to 55,117 shares valued at approximately $3.85 million.

Regarding insider transactions, Director Alexander Slusky divested 100,000 shares on May 12 at $118.08, trimming his stake by 18.7%. Insider Marvin Bradford Clevenger sold 15,549 shares on May 26 at $142.57, with the transaction attributed to tax withholding requirements on vested equity compensation.

Wall Street sentiment skews positive overall. Twelve analysts assign a Buy rating, three rate it Strong Buy, five recommend Hold, and one suggests Sell. The average price target among analysts is $102.76.

The equity has also gained from increased investor focus on space industry equities following SpaceX’s recent Nasdaq listing, prompting capital flows into aerospace-related stocks.

The post Rocket Lab (RKLB) Stock Soars 6.5% on KeyBanc Upgrade and Nasdaq-100 Entry Confirmed appeared first on Blockonomi.

Piyasa Fırsatı
LAB Logosu
LAB Fiyatı(LAB)
$9.80737
$9.80737$9.80737
-4.16%
USD
LAB (LAB) Canlı Fiyat Grafiği

World Cup Combo: Aim for 200x

World Cup Combo: Aim for 200xWorld Cup Combo: Aim for 200x

Combine up to 20 World Cup matches in one order

Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen crypto.news@mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Score Your Share of 50K USDT

Score Your Share of 50K USDTScore Your Share of 50K USDT

Complete DEX+ tasks to unlock the Champion Wheel